Sihuan Pharmaceutical Holdings Group Ltd banner

Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460

Watchlist Manager
Sihuan Pharmaceutical Holdings Group Ltd Logo
Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460
Watchlist
Price: 1.36 HKD 6.25%
Market Cap: HK$12.5B

Income Statement

Earnings Waterfall
Sihuan Pharmaceutical Holdings Group Ltd

Income Statement
Sihuan Pharmaceutical Holdings Group Ltd

Rotate your device to view
Income Statement
Currency: CNY
Sep-2006 Dec-2006 Mar-2007 Jun-2007 Sep-2007 Dec-2007 Mar-2008 Jun-2008 Sep-2008 Dec-2008 Mar-2009 Jun-2009 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025
Revenue
Interest Expense
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
117
99
211
134
269
268
275
247
Revenue
149
N/A
162
+9%
178
+10%
208
+17%
241
+16%
286
+19%
344
+20%
407
+18%
464
+14%
510
+10%
546
+7%
595
+9%
1 440
+142%
2 746
+91%
2 584
-6%
2 917
+13%
3 297
+13%
2 878
-13%
2 275
-21%
2 464
+8%
3 317
+35%
3 038
-8%
2 595
-15%
2 181
-16%
3 237
+48%
1 861
-43%
1 755
-6%
1 901
+8%
2 098
+10%
Gross Profit
Cost of Revenue
(41)
(37)
(36)
(40)
(40)
(61)
(78)
(103)
(125)
(134)
(148)
(162)
(422)
(759)
(590)
(538)
(578)
(589)
(565)
(550)
(721)
(608)
(628)
(694)
(1 002)
(565)
(598)
(659)
(707)
Gross Profit
108
N/A
125
+16%
141
+13%
168
+19%
201
+19%
226
+13%
266
+18%
304
+14%
340
+12%
377
+11%
398
+6%
433
+9%
1 018
+135%
1 987
+95%
1 994
+0%
2 379
+19%
2 719
+14%
2 289
-16%
1 710
-25%
1 914
+12%
2 596
+36%
2 430
-6%
1 967
-19%
1 488
-24%
2 235
+50%
1 296
-42%
1 156
-11%
1 242
+7%
1 390
+12%
Operating Income
Operating Expenses
(12)
(16)
(18)
(30)
(37)
(51)
(62)
(75)
(85)
(76)
(109)
(137)
(220)
(522)
(465)
(655)
(821)
(895)
(1 103)
(1 429)
(1 375)
(1 754)
(1 970)
(2 024)
(2 711)
(1 436)
(1 345)
(1 631)
(1 544)
Selling, General & Administrative
(23)
(28)
(30)
(36)
(45)
(62)
(80)
(91)
(93)
(92)
(96)
(101)
(340)
(857)
(977)
(667)
(547)
(717)
(725)
(859)
(1 049)
(1 129)
(1 139)
(1 023)
(1 448)
(911)
(940)
(1 175)
(1 165)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(480)
(714)
(599)
(666)
(729)
(762)
(868)
(992)
(937)
(1 231)
(578)
(479)
(474)
(431)
Other Operating Expenses
11
12
12
6
8
10
18
16
8
16
(13)
(36)
120
335
512
492
440
421
289
159
437
243
161
(64)
(32)
53
75
18
52
Operating Income
96
N/A
109
+14%
124
+13%
139
+12%
164
+18%
175
+7%
204
+17%
229
+13%
255
+11%
301
+18%
289
-4%
296
+2%
798
+170%
1 465
+84%
1 529
+4%
1 724
+13%
1 898
+10%
1 395
-27%
607
-56%
486
-20%
1 221
+151%
676
-45%
(3)
N/A
(536)
-16 198%
(476)
+11%
(141)
+70%
(188)
-34%
(389)
-107%
(154)
+60%
Pre-Tax Income
Interest Income Expense
(0)
(1)
(0)
(0)
(0)
11
3
5
8
11
13
10
73
138
124
289
332
154
105
124
62
(115)
(253)
(64)
(165)
(50)
17
(89)
(113)
Non-Reccuring Items
0
0
0
0
0
(1)
0
0
0
(24)
0
0
126
126
0
0
(2 844)
(3 972)
(1 128)
156
0
(65)
(11)
(1 523)
(1 515)
29
24
50
14
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
95
N/A
108
+14%
123
+14%
138
+12%
163
+18%
185
+13%
206
+12%
235
+14%
263
+12%
287
+9%
303
+5%
306
+1%
997
+226%
1 729
+73%
1 653
-4%
2 012
+22%
(614)
N/A
(2 423)
-295%
(416)
+83%
766
N/A
1 283
+68%
496
-61%
(267)
N/A
(2 123)
-694%
(2 156)
-2%
(161)
+93%
(147)
+9%
(428)
-191%
(252)
+41%
Net Income
Tax Provision
(16)
(18)
(20)
(5)
(6)
(6)
(6)
(28)
(33)
(54)
(63)
(67)
(157)
(250)
(228)
(333)
(435)
(290)
(187)
(219)
(311)
(253)
(180)
(197)
(283)
(96)
(59)
(43)
(85)
Income from Continuing Operations
79
90
103
134
158
179
200
207
231
233
240
240
840
1 479
1 425
1 679
(1 049)
(2 713)
(603)
547
972
243
(447)
(2 320)
(2 439)
(258)
(207)
(472)
(337)
Income to Minority Interest
0
0
1
1
1
0
0
3
2
4
5
9
2
(30)
(53)
(59)
(95)
4
66
(39)
(27)
184
303
368
438
204
169
255
257
Net Income (Common)
79
N/A
91
+14%
104
+15%
134
+29%
158
+18%
179
+13%
200
+12%
210
+5%
233
+11%
237
+2%
245
+3%
249
+2%
842
+238%
1 449
+72%
1 372
-5%
1 620
+18%
(1 166)
N/A
(2 753)
-136%
(583)
+79%
473
N/A
935
+97%
417
-55%
(155)
N/A
(1 915)
-1 139%
(1 965)
-3%
(54)
+97%
(38)
+30%
(217)
-473%
(81)
+63%
EPS (Diluted)
0.1
N/A
0.1
N/A
0.13
+30%
0.15
+15%
0.17
+13%
0.2
+18%
0.22
+10%
0.23
+5%
0.25
+9%
0.25
N/A
0.25
N/A
0.26
+4%
0.09
-65%
0.15
+67%
0.14
-7%
0.17
+21%
-0.12
N/A
-0.29
-142%
-0.06
+79%
0.05
N/A
0.1
+100%
0.05
-50%
-0.02
N/A
-0.21
-950%
-0.21
N/A
-0.01
+95%
0
N/A
-0.02
N/A
-0.01
+50%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett